Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction

Fig. 5

Correlations between RIPK2 expression and immunotherapy response. A Kaplan–Meier survival plots (OS) comparing high and low expression of RIPK2 in SKCM and KIRC cohort studies treated with anti-PD1 drug. B The plot showed the prognostic value of RIPK2 versus standardized biomarkers in SKCM and KIRC cohort. C The bar chart showed the correlation between RIPK2 and standardized biomarkers in the immunotherapy cohorts. The area under the recipient’s working characteristic curve (AUC) was used to evaluate the predictive performance of the test biomarker to the immunotherapy response state

Back to article page

Molecular Medicine

ISSN: 1528-3658